The purification of cerebroside sulfate activator (CSAct) or saposin B from pooled human urine is described. Urinary proteins are concentrated by ammonium sulfate precipitation. A suspension of the precipitate is heat-treated and the heat-stable proteins are fractionated through a series of chromatographic steps. An initial concanavalin A column retains little of the CSAct activity, but is important for subsequent purification. Passing the Con A effluent directly onto an octyl Sepharose column removes the protein of interest which is recovered by affinity elution with octyl glucoside. Subsequent ion-exchange and gel filtration chromatographies yield a protein of 80-90% purity, although it is sometimes necessary to repeat one or more steps. A small amount of CSAct can sometimes be recovered from the initial Con A Sepharose column by methyl mannoside elution and purified by a parallel chromatographic protocol. Mass spectral analysis suggests that the final material is a mixture of two major and several minor glycoforms of a 79 amino acid protein with the structure predicted from the human prosaposin cDNA by truncation of both N- and C-terminal regions. Sugar analysis revealed the presence of glucosamine, mannose, and fucose, consistent with the major isoforms bearing a five-sugar Man(2)GluNac(2)Fuc or a single GluNac substituent. The human urinary material is similar to the previously characterized pig kidney protein in most respects, but varies in some details.

Download full-text PDF

Source
http://dx.doi.org/10.1006/mgme.1999.2900DOI Listing

Publication Analysis

Top Keywords

cerebroside sulfate
8
sulfate activator
8
activator csact
8
csact saposin
8
human urine
8
sepharose column
8
preparation cerebroside
4
csact
4
human
4
saposin human
4

Similar Publications

Article Synopsis
  • Metachromatic leukodystrophy (MLD) is an autosomal recessive disorder caused by a deficiency in arylsulfatase A, leading to accumulation of cerebroside sulfate and subsequent demyelination.
  • Clinical symptoms differ with age: late-infantile has rapid progression, juvenile shows slower decline, and adult-onset may present with psychiatric issues.
  • Diagnosis involves enzyme testing, imaging, and other criteria, and while there's no cure for MLD, management focuses on supportive care and potential treatments like hematopoietic stem cell transplantation.
View Article and Find Full Text PDF

Metachromatic leukodystrophy (MLD) is a lysosomal storage disease resulting from a deficiency of arylsulfatase A causing an accumulation of cerebroside sulfate, a lipid normally abundant in myelin. Sulfatide accumulation is associated with progressive demyelination and a clinical presentation in severe disease forms that is dominated by motor manifestations. Cerebral inflammation may contribute to the pathophysiology of MLD.

View Article and Find Full Text PDF

A Rare Case of Metachromatic Leukodystrophy Confirmed by Arylsulfatase A.

Mymensingh Med J

October 2015

Dr Syeda Tabassum Alam, Associate Professor, Paediatric Neurology, Department of Paediatrics, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh.

Metachromatic leukodystrophy (MLD) is the rare neurometabolic disease caused by the deficiency of a lysosomal enzyme arylsulfatase A (ARSA) activity. The absence or deficiency of arylsulfatase a leads to accumulation of cerebroside sulfate within the myelinseath of the central nervous system (CNS) and the peripheral nervous system (PNS). This in turn causes the CNS and PNS to progressively deteriorate leading to both features of upper and lower motor neuron dysfunctions.

View Article and Find Full Text PDF

Determination of arylsulfatase A pseudodeficiency allele and haplotype frequency in the Tunisian population.

Neurol Sci

March 2016

Laboratoire de Génomique Biomédicale et Oncogénétique, Institut Pasteur de Tunis, BP 74, 13 Place Pasteur, 1002, Tunis, Belvédère, Tunisia.

Arylsulfatase A (ASA) is a lysosomal enzyme involved in the catabolism of cerebroside sulfate. ASA deficiency is associated with metachromatic leukodystrophy (MLD). Low ASA activities have also been reported in a more common condition with no apparent clinical consequences termed ASA pseudo-deficiency (ASA-PD) which is associated with two linked mutations in the ASA gene (c.

View Article and Find Full Text PDF

A capillary electrophoresis method with dynamic pH junction stacking for the monitoring of cerebroside sulfotransferase.

J Chromatogr A

August 2015

PharmaCenter Bonn, Pharmaceutical Institute, Pharmaceutical Chemistry I, University of Bonn, An der Immenburg 4, 53121 Bonn, Germany. Electronic address:

Metachromatic leukodystrophy (MLD) is a rare and severe genetic disease. Inhibition of cerebroside sulfotransferase (CST) has been proposed as a promising new therapeutic strategy for the treatment of MLD. CST catalyzes the transfer of a sulfate group from the coenzyme 3'-phosphoadenosine-5'-phosphosulfate (PAPS) to cerebroside yielding cerebroside sulfate and adenosine-3',5'-diphosphate (PAP).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!